Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Alzheimers Res Ther. 2024 Jul 10;16(1):159. doi: 10.1186/s13195-024-01507-7.
NO ABSTRACT
PMID:38987826 | DOI:10.1186/s13195-024-01507-7
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 1 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Correction: Polygenic effects on the risk of Alzheimer's disease in the Japanese population Updated safety results from phase 3 lecanemab study in early Alzheimer's disease Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer's disease patients: a pilot study Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer's disease patients: a pilot study Correction: Administration of adipose-derived stem cells extracellular vesicles in a murine model of spinal muscular atrophy: effects of a new potential therapeutic strategy A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer Passive immunotherapy for Alzheimer's disease: challenges & future directions Exploring morphological similarity and randomness in Alzheimer's disease using adjacent grey matter voxel-based structural analysis Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data Prescription medication use in the 10 years prior to diagnosis of young onset Alzheimer's disease: a nationwide nested case-control study Prescription medication use in the 10 years prior to diagnosis of young onset Alzheimer's disease: a nationwide nested case-control study Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial Quantitative transport mapping of multi-delay arterial spin labeling MRI detects early blood perfusion alterations in Alzheimer's disease Correction: Palliative care for persons with late-stage Alzheimer's and related dementias and their caregivers: protocol for a randomized clinical trial Correction: Palliative care for persons with late-stage Alzheimer's and related dementias and their caregivers: protocol for a randomized clinical trial Correction: Olfactory bulb anomalies in KBG syndrome mouse model and patients Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model Memory and belief updating following complete and partial reminders of fake news Lecanemab blocks the effects of the Ab/fibrinogen complex on blood clots and synapse toxicity in organotypic culture Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial Correction: Effectiveness of a school-based Life Gatekeeper Training Program on suicide prevention in China: protocol for a randomized controlled trial Development of disease-modifying therapies against Alzheimer's disease Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-ADmini) Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease Correction: Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease Distinct effects of blood pressure parameters on Alzheimer's and vascular markers in 1,952 Asian individuals without dementia Irregular word reading as a marker of semantic decline in Alzheimer's disease: implications for premorbid intellectual ability measurement N, N-Dimethyltryptamine, a natural hallucinogen, ameliorates Alzheimer's disease by restoring neuronal Sigma-1 receptor-mediated endoplasmic reticulum-mitochondria crosstalk Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patterns Central autonomic network dysfunction and plasma Alzheimer's disease biomarkers in older adults Central autonomic network dysfunction and plasma Alzheimer's disease biomarkers in older adults Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review Pathophysiology characterization of Alzheimer's disease in South China's aging population: for the Greater-Bay-Area Healthy Aging Brain Study (GHABS) The relation of synaptic biomarkers with Aβ, tau, glial activation, and neurodegeneration in Alzheimer's disease Serum urate levels and neurodegenerative outcomes: a prospective cohort study and mendelian randomization analysis of the UK Biobank Plasma biomarkers of amyloid, tau, axonal, and neuroinflammation pathologies in dementia with Lewy bodies Cholecystokinin B receptor agonists alleviates anterograde amnesia in cholecystokinin-deficient and aged Alzheimer's disease mice Association between retinal microvascular abnormalities and late-life brain amyloid-b deposition: the ARIC-PET study Correction: Ethical use of artificial intelligence to prevent sudden cardiac death: an interview study of patient perspectives Plasma biomarkers increase diagnostic confidence in patients with Alzheimer's disease or frontotemporal lobar degeneration Publisher Correction: Medical student wellbeing during COVID-19: a qualitative study of challenges, coping strategies, and sources of support Publisher Correction: Medical student wellbeing during COVID-19: a qualitative study of challenges, coping strategies, and sources of support Biophysical models applied to dementia patients reveal links between geographical origin, gender, disease duration, and loss of neural inhibition Author Correction: Trans-ancestral genome-wide association study of longitudinal pubertal height growth and shared heritability with adult health outcomes Artificial Intelligence in Eye Movements Analysis for Alzheimer's Disease Early Diagnosis Correction: Assessing real-world gait with digital technology? Validation, insights and recommendations from the Mobilise-D consortium Correction: Experimental evaluation of the impact of sEMG interfaces in enhancing embodiment of virtual myoelectric prostheses Correction: Rebuilding the health sector in Gaza: alternative humanitarian voices N-terminal pro-brain natriuretic peptide - a significant biomarker of disease development and adverse prognosis in patients with exertional heat stroke Correction: Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade Correction: Defining and reporting exercise intensity in interventions for older adults: a modified Delphi process Correction: Improvements in lung function following vitamin C supplementation to pregnant smokers are associated with buccal DNA methylation at 5 years of age Correction: SNCA genetic lowering reveals differential cognitive function of alpha-synuclein dependent on sex
Evidence Blueprint
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Correction: Updated safety results from phase 3 lecanemab study in early Alzheimer’s disease
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Correction: Polygenic effects on the risk of Alzheimer's disease in the Japanese population Updated safety results from phase 3 lecanemab study in early Alzheimer's disease Correction: Neuron‑derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's disease Correction: Is later‑life depression a risk factor for Alzheimer's disease or a prodromal symptom: a study using post‑mortem human brain tissue? Correction: Reduction of NgR in perforant path decreases amyloid-β peptide production and ameliorates synaptic and cognitive deficits in APP/PS1 mice Correction: Reduction of NgR in perforant path decreases amyloid-β peptide production and ameliorates synaptic and cognitive deficits in APP/PS1 mice Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer's disease patients: a pilot study Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer's disease patients: a pilot study The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials Correction: Administration of adipose-derived stem cells extracellular vesicles in a murine model of spinal muscular atrophy: effects of a new potential therapeutic strategy A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer Passive immunotherapy for Alzheimer's disease: challenges & future directions A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease Lecanemab Questions Navigating the metabolic maze: anomalies in fatty acid and cholesterol processes in Alzheimer's astrocytes Correction: Lesion of the subiculum reduces the spread of amyloid beta pathology to interconnected brain regions in a mouse model of Alzheimer's disease Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: a systematic review and network meta-analysis Exploring morphological similarity and randomness in Alzheimer's disease using adjacent grey matter voxel-based structural analysis Associations of cerebrospinal fluid complement proteins with Alzheimer's pathology, cognition, and brain structure in non-dementia elderly White matter integrity is associated with cognition and amyloid burden in older adult Koreans along the Alzheimer's disease continuum Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data Correction: Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trial Correction: Detection of β-amyloid aggregates/plaques in 5xFAD mice by labelled native PLGA nanoparticles: implication in the diagnosis of Alzheimer's disease Cost-Effectiveness of Lecanemab for Individuals With Early-Stage Alzheimer Disease Prescription medication use in the 10 years prior to diagnosis of young onset Alzheimer's disease: a nationwide nested case-control study Prescription medication use in the 10 years prior to diagnosis of young onset Alzheimer's disease: a nationwide nested case-control study Synaptic vesicle glycoprotein 2 A in serum is an ideal biomarker for early diagnosis of Alzheimer's disease Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial Quantitative transport mapping of multi-delay arterial spin labeling MRI detects early blood perfusion alterations in Alzheimer's disease A systematic review on machine learning and deep learning techniques in the effective diagnosis of Alzheimer's disease Correction: Comprehensive genetic screening of early-onset dementia patients in an Austrian cohort-suggesting new disease-contributing genes Correction: Palliative care for persons with late-stage Alzheimer's and related dementias and their caregivers: protocol for a randomized clinical trial Correction: Palliative care for persons with late-stage Alzheimer's and related dementias and their caregivers: protocol for a randomized clinical trial Correction: Olfactory bulb anomalies in KBG syndrome mouse model and patients Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model Memory and belief updating following complete and partial reminders of fake news Lecanemab blocks the effects of the Ab/fibrinogen complex on blood clots and synapse toxicity in organotypic culture Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial Correction: Effectiveness of a school-based Life Gatekeeper Training Program on suicide prevention in China: protocol for a randomized controlled trial Development of disease-modifying therapies against Alzheimer's disease Experimental colitis in young Tg2576 mice accelerates the onset of an Alzheimer's-like clinical phenotype Bayesian meta-analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high-dose gantenerumab in prodromal and mild Alzheimer's disease Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-ADmini) A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol Clinical application of plasma P-tau217 to assess eligibility for amyloid-lowering immunotherapy in memory clinic patients with early Alzheimer's disease Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals Machine learning prediction of future amyloid beta positivity in amyloid-negative individuals Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years Correction: Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson's disease Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer's Disease Sex matters in the association between cardiovascular health and incident dementia: evidence from real world data The relation of a cerebrospinal fluid profile associated with Alzheimer's disease with cognitive function and neuropsychiatric symptoms in sporadic cerebral amyloid angiopathy Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer's Disease Correction: Phenotype and genotype heterogeneity of PLA2G6-associated neurodegeneration in a cohort of pediatric and adult patients Correction: Validation of Oura ring energy expenditure and steps in laboratory and free‑living Distinct effects of blood pressure parameters on Alzheimer's and vascular markers in 1,952 Asian individuals without dementia Polygenic effects on the risk of Alzheimer's disease in the Japanese population Estimating demand for potential disease-modifying therapies for Alzheimer's disease in the UK Irregular word reading as a marker of semantic decline in Alzheimer's disease: implications for premorbid intellectual ability measurement Correction: Children's rights and restrictive measures during the COVID-19 pandemic: implications for politicians, mental health experts and society Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis
Inbrain